Loading clinical trials...
Loading clinical trials...
The purpose of this study is to assess the safety and effectiveness of IDP-115 in treating patients with rosacea.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Dow Pharmaceutical Sciences
NCT07106957 · Erythematous Telangiectatic Rosacea
NCT06466018 · Ocular Rosacea, Pachychoroid Disease
NCT04108897 · Rosacea
NCT07250165 · Rosacea
NCT04214483 · Acne, Acne Vulgaris, and more
Medical Affiliated Research Center, Inc.
Huntsville, Alabama
Therapeutics Clinical Research
San Diego, California
Solano Clinical Research
Vallejo, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions